Health TrialsbyHealthPanel

Molecular Inflammation Board at the Center for Personalized Medicine

ConditionsPsoriasis (PsO)Psoriasis ArthritisInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)Spondylarthropathies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Tuebingen

About this trial

Molecular Inflammation Board at the Center for Personalized Medicine

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Chronic inflammatory disorder (PsO, PsA, SpA, IBD)

Given informed consent

18 years of age

Disqualifiers

No capacity to consent

Trial population

Patients with chronic inflammatory diseases and indication for therapy with biologic agents

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Biologic Agent

    Biological/Vaccine

    Intervention with biologic agents

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Therapy persistence

Duration of intervention with biological agent

Time frame
Through study completion, an average of 1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital Tuebingen

Lead sponsor

University Hospital Freiburg

Collaborator

University Hospital Heidelberg

Collaborator

University Hospital Ulm

Collaborator

Source ClinicalTrials.gov
Apply now